鶹ýӰ

Sticky Patch Defibrillator; State Telehealth Laws and BP Meds; Ketones and HFpEF?

— Recent developments of interest in cardiovascular medicine

MedpageToday
Cardio Break over a computer rendering of a heart.

The delivered successful shocks for protection from sudden cardiac arrest, and people were highly compliant to wearing the water-resistant device. (Journal of the American College of Cardiology)

People with long QT syndrome could perform without experiencing excess cardiac events, according to observational data. (Circulation)

A reportedly had a cardiac episode while on the job, which caused him to crash into a Burger King. (ABC7)

In patients with persistent atrial fibrillation, additional did not improve clinical outcomes compared with pulmonary vein isolation alone, a small trial found. (Circulation: Arrhythmia and Electrophysiology)

Dapagliflozin (Farxiga) may confer benefits in heart failure with preserved ejection fraction (HFpEF) via its effects on associated with pulmonary capillary wedge pressure reduction. (JAMA Cardiology)

A ketone supplement could help heart metabolism in , according to preclinical research highlighted by the American Heart Association.

were associated with greater blood pressure medication adherence. (Circulation: Cardiovascular Quality and Outcomes)

The OPTiMISE trial's continued to be safe for some elderly people with controlled blood pressure. (Lancet Healthy Longevity)

The first-in-human implantation of the was successful as a bridge to transplant, according to the Texas Heart Institute.

A study validated the prognostic value of looser criteria for . (European Heart Journal)

The continued to show good safety for left atrial appendage occlusion in a postapproval registry. (Circulation: Cardiovascular Interventions)

Can automated predict mitral annular dimensions and left ventricular outflow tract obstruction risk before transcatheter mitral valve replacement? (JACC: Cardiovascular Imaging)

The CETP inhibitor reduced LDL cholesterol by 41.5% at 1 year in the phase III BROOKLYN trial in heterozygous familial hypercholesterolemia, NewAmsterdam Pharma announced.

The benefits of endovascular thrombectomy for strokes with large infarct were in the TENSION trial. (Lancet Neurology)

appeared feasible soon after a stroke, as people did not suffer more stroke complications. (Annals of Thoracic Surgery)

Daily low-dose aspirin did not halt the progression of in ASPREE. (JAMA Network Open)

  • author['full_name']

    Nicole Lou is a reporter for MedPage Today, where she covers cardiology news and other developments in medicine.